Following approval at the December 2025 NENC Clinical Effectiveness and Governance (CEG) Subcommittee the following updated guidelines have now been published on the NTAG website:
- North East Guideline For Use Of Sodium Glucose Co transporter 2 Inhibitors (SGLT2i) – updated to reflect availability of generic dapagliflozin https://ntag.nhs.uk/wp-content/uploads/2026/02/NENC-regional-SGLT2-top-tips-v4-approved-Dec-2025.pdf
Following approval at the January 2026 NENC Clinical Effectiveness and Governance (CEG) Subcommittee the following new prescribing policy has now been published on the NTAG website:
- NENC ICB Gluten-Free Prescribing Policy https://ntag.nhs.uk/wp-content/uploads/2026/02/NENC-ICB-Gluten-Free-Policy-approved-Jan-2026.pdf